Application of the Morita-Baylis-Hillman reaction in the synthesis of 3-[(N-cycloalkylbenzamido)methyl]-2-quinolones as potential HIV-1 integrase inhibitors

Bioorg Chem. 2017 Dec:75:310-316. doi: 10.1016/j.bioorg.2017.09.015. Epub 2017 Sep 22.

Abstract

A practicable six-step synthetic pathway has been developed to access a library of novel 3-[(N-cycloalkylbenzamido)methyl]-2-quinolones using Morita-Baylis-Hillman methodology. These compounds and their 3-[(N-cycloalkylamino)methyl]-2-quinolone precursors have been screened as potential HIV-1 integrase (IN) inhibitors. A concomitant survey of their activity against HIV-1 protease and reverse-transcriptase reveals selective inhibition of HIV-1 IN.

Keywords: 2-quinolones; Bioassay; HIV-1 integrase inhibitors; Morita_Baylis-Hillman; Synthesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Survival / drug effects
  • Enzyme Activation / drug effects
  • HEK293 Cells
  • HIV Integrase / chemistry*
  • HIV Integrase / metabolism
  • HIV Integrase Inhibitors / chemical synthesis*
  • HIV Integrase Inhibitors / metabolism
  • HIV Integrase Inhibitors / pharmacology
  • HIV Reverse Transcriptase / antagonists & inhibitors
  • HIV Reverse Transcriptase / metabolism
  • HIV-1 / enzymology*
  • Humans
  • Quinolones / chemistry*
  • Quinolones / metabolism
  • Quinolones / pharmacology
  • Structure-Activity Relationship

Substances

  • HIV Integrase Inhibitors
  • Quinolones
  • HIV Integrase
  • reverse transcriptase, Human immunodeficiency virus 1
  • HIV Reverse Transcriptase